Funding Boost for Holo’s Health Innovation
Barcelona-based startup Holo has successfully completed a pre-Seed funding round, raising €1 million to enhance how individuals monitor and manage their health. The investment aims to develop an all-in-one application that merges advanced laboratory testing, artificial intelligence, and functional medicine with popular wearable devices like the Apple Watch, Garmin, and Oura. The funding round was primarily led by Calm/Storm Ventures and Mission VC, with additional contributions from ENISA and a variety of business angels, including notable investors such as Javier López from Magnific AI and Emilio Nicolás from Freepik.
Transforming Health Management
According to Francesc Navarro, CEO and co-founder of Holo, the goal is to empower individuals to take charge of their health proactively rather than waiting for issues to arise. He expressed the vision of making health management as effortless as managing personal finances, describing the aspiration to create “the Revolut of health.” This ambition aligns with a broader trend across Europe, where several startups focused on preventive health and diagnostics have recently announced significant funding rounds.
In a similar vein, other European startups are securing funding to expand their preventive health services. For instance, Aeon from Switzerland raised €8.2 million for its AI-based health platform, while Blue Longevity Clinic in Bulgaria obtained €2 million to broaden its longevity-focused services. Collectively, these initiatives reflect a growing investor interest in health technologies that promote preventive care instead of merely reactive treatments.
Innovative Health Solutions
Founded in 2024 by a trio of former members from the unicorn startup Factorial, Holo was inspired by the notion that health begins in everyday life rather than in clinical settings. The platform allows users to undergo comprehensive lab tests at leading laboratories, link their wearable devices, and receive tailored medical reports from specialists in preventive care and longevity. This service provides users with a detailed health profile, assessing over 110 biomarkers, which can indicate various health conditions and overall well-being.
As noted by Emilio Rodríguez, co-founder and Chief Product Officer, the platform aims to revolutionize health accessibility by ensuring that users can manage their health data efficiently. He stated that in the near future, everyone will have a comprehensive health profile readily available, which could significantly enhance everyday well-being and disease prevention.
Future Plans and Market Positioning
With the recent funding, Holo plans to solidify its presence in Spain while also preparing for a wider European launch in 2026. The funds will be allocated to product development, establishing new medical integrations, and fostering clinical partnerships throughout Europe. Holo is already collaborating with Laboratorios Echevarne in Spain to enhance its offerings and is working on additional personalized longevity services, reinforcing its ambition to become a leader in the preventive health sector across Europe.
Lucanus Polagnoli, General Partner at Calm/Storm Ventures, expressed confidence in Holo’s potential, emphasizing the team’s expertise and execution capabilities. He highlighted that the founders’ experience from Factorial positions them well to address the growing demand for preventive health solutions in Europe, a market currently seen as underserved.
As Holo embarks on this journey, it aims to set new standards in health monitoring and preventive care, paving the way for a more health-conscious society.
Related
